Trial Profile

Evaluation of Drug Interactions of Saxagliptin With Sildenafil in Healthy Volunteers

Status: Completed

Phase of Trial: Clinical Phase Unknown

Latest Information Update: 13 Oct 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Saxagliptin (Primary) ; Sildenafil (Primary)
Indications Diastolic heart failure; Erectile dysfunction; Heart failure; Pulmonary arterial hypertension; Pulmonary hypertension; Type 2 diabetes mellitus
Focus Adverse reactions; Pharmacokinetics

Most Recent Events

10 Oct 2022 Primary endpoint (ka) has been met, according to Results published in the European Journal of Clinical Pharmacology.
10 Oct 2022 Primary endpoint (Ke) has been met, according to Results published in the European Journal of Clinical Pharmacology.
10 Oct 2022 Primary endpoint (T) according to Results published in the European Journal of Clinical Pharmacology.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com